Compare Google Inc (GOOG) vs Sanofi SA (SNY) Price & Performance

Google IncTrade

Sanofi SATrade

Price performance (Past 24H)

Key statistics

Google Inc vs Sanofi SA — how do they compare? Google Inc trades at $372 (market cap $4.52T), while Sanofi SA trades at $43.7 (market cap $103.94B). The key difference: Google Inc is far larger — about 43.5× Sanofi SA's market cap, and Sanofi SA pays the higher dividend (5.54%). Which is the better fit depends on your goals.

	GOOG	SNY
Market Cap	$4.52T	$103.94B
Volume	1,511,127	—
Sector	Technology	Health
52-Week High	$399.06	$52.34
52-Week Low	$183.77	$41.33
Enterprise Value	$4.49T	$120.43B
Dividend Yield	0.24%	5.54%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Google Inc

GOOG trades at $357.33, up 1.9% today, with a bullish technical signal and strong support at $353. The company shows robust fundamentals with 2025 revenue of $402.84B, net income of $132.17B, and a net margin of 32.8%. Recent earnings beats and a consensus analyst price target of $457.50 highlight positive momentum, while news includes Warren Buffett's endorsement and strategic AI partnerships.

Outlook remains positive driven by earnings growth and AI expansion, but risks include regulatory fines and competitive pressures. Wall Street sentiment is strongly bullish with 87% buy ratings, suggesting upside potential, though investors should monitor execution and macroeconomic factors.

Sanofi SA

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GOOG

Alphabet stock rises on AI, cloud growth, and strong investor backing including Berkshire Hathaway.Tony Dante · 5 hours agoBullish Alphabet stock rises after legal win and Berkshire Hathaway's big investmentTony Dante · 6 hours agoBullish US ITC investigates Samsung and partners for alleged patent infringement on memory products.PRNewsWire · 7 hours agoBearish View details →

SNY

Global blood glucose monitoring market to nearly double to $39.4B by 2035 with 8.9% CAGR driven by AI and home care trendsCustom Market Insights · 2 days agoBullish Lakefront Biotherapeutics board member Paulo Fontoura resigns after joining Sanofi as Global Head of R&DGlobeNewsWire · 2 days agoNeutral View details →

About Google Inc

Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.